# Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy

> **NCT03179891** · PHASE2 · COMPLETED · sponsor: **Aquestive Therapeutics** · enrollment: 35 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Diazepam Buccal Film 12.5 mg

## Key facts

- **NCT ID:** NCT03179891
- **Lead sponsor:** Aquestive Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-25
- **Primary completion:** 2018-07-25
- **Final completion:** 2018-12-21
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2020-09-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03179891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03179891, "Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03179891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*